Abiraterone Ethyl Ether Impurity

Status: Under Development

Abiraterone Ethyl Ether Impurity or 1-((8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,7,8,9,10,11,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl)ethan-1-one,is a derivative of steroidal progesterone and is used in the treatment of prostate cancer.

Contact us

Additional information on Abiraterone Ethyl Ether Impurity

Catalogue No. VL830020
Molecular Formula C26H35NO
Molecular Weight 377.57
Parent drug Abiraterone
IUPAC Name 1-((8R, 9S, 10R, 13S, 14S)-10, 13-Dimethyl-17-(pyridin-3-yl)-2, 7, 8, 9, 10, 11, 12, 13, 14, 15-decahydro-1H-cyclopenta[a]phenanthren-3-yl)ethan-1-one
Synonyms N/A
References Thakur, Abhimanyu, et al. “Abiraterone Acetate in the Treatment of Prostate Cancer.” Biomedicine & Pharmacotherapy, vol. 101, May 2018, pp. 211–218, 10.1016/j.biopha.2018.02.067.
Status Under Development

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

Abiraterone Ethyl Ether Impurity

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.